In a phase 1 trial, Novo Nordisk's experimental obesity drug amycretin led to up to 13% weight loss in just three months.

LOTTIE Moss has bravely opened up about her struggles with body image, which at one point saw her go on Ozempic. It’s the ...

The House and Senate are racing to complete the government funding process with the Sept. 30 shutdown deadline looming and lawmakers eager to head back to their districts to campaign ahead of the ...

Compounded semaglutide has emerged as a significant development in the management of obesity and type 2 diabetes. As a ...

Prescription weight loss drugs have become so popular in the United States that suppliers have struggled to keep up.

An exciting new Irish study has found that Semaglutide, the substance found in popular weight-loss drugs Ozempic and Wegovy, ...

A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...

Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...

Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...

Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect ...

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...